The Elevate 90
What Is Purple ELEVATE™?
Purple ELEVATE™ is a 90-day structured research protocol designed to examine metabolic signaling, endocrine communication, mitochondrial responsiveness, and tissue-integrity pathways through a coordinated systems-based framework.
Rather than focusing on a single biological pathway, Purple ELEVATE™ brings together four research compounds commonly studied across complementary areas of metabolic and cellular biology: Tirzepatide, CJC-1295 + Ipamorelin, MOTS-c, and GHK-Cu.
This protocol was developed for research models focused on female-centered metabolic signaling, hormone-environment balance, mitochondrial communication, recovery-related pathways, connective-tissue support models, and long-duration biological adaptation.
Purple ELEVATE™ is not designed as an aggressive single-pathway protocol. It is designed as an intentional, structured research system for observing how multiple signaling layers may interact over time.
Certificate of Analysis
Third-party testing documentation available for purity and analytical verification.
Purple ELEVATE™ Research Overview
Purple ELEVATE™ is a 90-day research protocol built around the concept that biological adaptation is often better studied through coordinated signaling rather than isolated stimulation.
The protocol includes research compounds associated with four major areas of investigation:
- Metabolic Signaling: Tirzepatide is studied for dual GIP and GLP-1 receptor activity, glucose-response models, insulin-related pathways, appetite-related signaling, and systemic energy regulation.
- Endocrine Communication: CJC-1295 + Ipamorelin is studied for growth hormone–related signaling, IGF-1 pathway research, pituitary-response models, and upstream endocrine rhythm communication.
- Mitochondrial Responsiveness: MOTS-c is studied as a mitochondrial-derived peptide involved in energy sensing, AMPK-related pathways, metabolic flexibility, cellular stress response, and mitochondrial-to-nuclear communication.
- Tissue Integrity: GHK-Cu is studied for collagen regulation, fibroblast activity, extracellular matrix remodeling, angiogenic signaling, copper-dependent pathways, and skin/connective-tissue research models.
Together, these compounds create a broader research platform for studying how metabolic, endocrine, mitochondrial, and structural signaling systems may interact in controlled laboratory settings.
What’s Included in Purple ELEVATE™
Why the ELEVATE™ Protocol Exists
Many research protocols focus on intensity, speed, or a single biological target. Purple ELEVATE™ was developed from a broader perspective: long-term adaptation is often more meaningful when multiple biological systems are observed together.
Female-centered metabolic research often involves overlapping systems, including endocrine rhythm, energy signaling, appetite-related pathways, mitochondrial responsiveness, recovery patterns, connective-tissue signaling, and body-composition dynamics.
Purple ELEVATE™ was built to provide a more complete research framework for examining these systems across a structured 90-day observation window.
The Science Behind the Stack
Tirzepatide
Tirzepatide is studied as a dual GIP and GLP-1 receptor agonist. These incretin pathways are associated with glucose regulation, insulin-response signaling, appetite-related biology, and broader metabolic communication.
In research settings, Tirzepatide is included as the primary metabolic-signaling component of Purple ELEVATE™. Its role is to support investigation into dual incretin pathway activity, energy-balance signaling, insulin-related response models, and integrated endocrine-metabolic communication.
CJC-1295 + Ipamorelin
CJC-1295 is studied as a long-acting GHRH analog associated with growth hormone and IGF-1 pathway research. Ipamorelin is studied as a selective growth hormone secretagogue associated with GHS-R pathway activity and GH-release models.
Together, CJC-1295 + Ipamorelin provide an endocrine-signaling research component. This pairing is commonly examined in models related to growth hormone pulsatility, pituitary response, IGF-1 signaling, recovery-related pathways, and biological rhythm alignment.
MOTS-c
MOTS-c is a 16–amino acid mitochondrial-derived peptide encoded within mitochondrial DNA. It is studied for its relationship with cellular energy sensing, metabolic flexibility, AMPK-related signaling, glucose metabolism, and adaptive stress-response pathways.
Within Purple ELEVATE™, MOTS-c represents the mitochondrial and intracellular energy-signaling component. Its inclusion supports research into how mitochondrial-derived peptides may influence metabolic adaptation, cellular resilience, and energy-demand response models.
GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide complex studied for its relationship with collagen regulation, extracellular matrix remodeling, fibroblast activity, angiogenic signaling, antioxidant-response pathways, and skin/connective-tissue biology.
Within Purple ELEVATE™, GHK-Cu represents the structural and tissue-integrity component. Its inclusion reflects the importance of connective-tissue signaling, skin-related research models, and extracellular matrix support alongside metabolic and endocrine research domains.
Why These Compounds Are Paired
Purple ELEVATE™ is built around systems-level coordination.
- Tirzepatide is studied for metabolic and incretin signaling.
- CJC-1295 + Ipamorelin is studied for endocrine and GH/IGF-1 pathway communication.
- MOTS-c is studied for mitochondrial energy signaling and adaptive stress response.
- GHK-Cu is studied for tissue integrity, collagen regulation, and extracellular matrix remodeling.
Together, these compounds create a multi-layered research framework for observing coordinated biological adaptation across metabolic, endocrine, mitochondrial, and structural pathways. This makes Purple ELEVATE™ useful for long-duration research models where investigators want to observe broader signaling patterns rather than isolated compound activity.
Research Applications
Purple ELEVATE™ may be useful in controlled research models focused on:
- Female-centered metabolic signaling dynamics
- Long-duration systems-level adaptation
- Incretin and endocrine pathway interaction
- Mitochondrial responsiveness and energy signaling
- GH/IGF-1 pathway research
- Connective-tissue and extracellular matrix signaling
- Recovery-related biological markers
- Body-composition and metabolic-balance research models
- Structured observation across multiple biological domains
What Researchers May Document
In controlled research environments, Purple ELEVATE™ may be used in protocols where broader biological patterns are documented over time, including:
- Energy-related observations
- Appetite-pattern research
- Metabolic-response markers
- Recovery-related signaling
- Training-response models
- Body-composition trends
- Sleep and rhythm-related observations
- Skin and tissue-related research notes
- Structural and connective-tissue response models
The goal of Purple ELEVATE™ is not intensity. The goal is structured observation across multiple biological systems.
The Purple Standard™
Every vial included in Purple ELEVATE™ is handled according to the Purple Standard™. This includes third-party testing, purity verification, controlled storage conditions, batch tracking, and internal rejection of any lot that does not meet required quality thresholds.
The Purple Standard™ exists to support consistency, documentation, and research confidence across every Purple Protocol™.
Investigational Research Context
Purple ELEVATE™ should be considered an investigational research protocol. Available scientific literature primarily examines the included compounds individually or in related research contexts. Findings should not be interpreted as approved therapeutic, cosmetic, clinical, veterinary, or human-use outcomes for the protocol.
This product is supplied for laboratory research only and is not intended for human consumption, clinical use, veterinary use, diagnostic use, or self-experimentation.
Scientific References
View References
Tirzepatide / GLP2-T Research
- Coskun T. et al. (2018) — LY3298176, a novel dual GIP and GLP-1 receptor agonist: from discovery to clinical proof of concept.
- Willard F.S. et al. (2020) — Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
- Jastreboff A.M. et al. (2022) — Tirzepatide once weekly for the treatment of obesity.
- Garvey W.T. et al. (2023) — Tirzepatide once weekly for obesity in people with type 2 diabetes.
CJC-1295 + Ipamorelin Research
- Teichman S.L. et al. (2006) — Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295.
- Ionescu M. et al. (2006) — Pulsatile secretion of growth hormone persists during continuous stimulation by CJC-1295.
- Sackmann-Sala L. et al. (2009) — Activation of the GH/IGF-1 axis by CJC-1295.
- Raun K. et al. (1998) — Ipamorelin, the first selective growth hormone secretagogue.
- Gobburu J.V.S. et al. (1999) — Pharmacokinetic-pharmacodynamic modeling of Ipamorelin.
MOTS-c Research
- Lee C. et al. (2015) — The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
- Kim K.H. et al. (2018) — The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress.
- Reynolds J.C. et al. (2021) — MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.
- Zheng Y. et al. (2023) — MOTS-c: A promising mitochondrial-derived peptide for metabolic and aging-related research.
GHK-Cu Research
- Pickart L. et al. (2015) — GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.
- Pickart L. & Margolina A. (2018) — Regenerative and protective actions of the GHK-Cu peptide in the light of new gene data.
- Wegrowski Y. et al. (1992) — Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex GHK-Cu.
- Siméon A. et al. (2000) — Modulation of wound extracellular matrix components by GHK-Cu.
Need Help?
